nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—hypertension—focal segmental glomerulosclerosis	0.973	1	CtDrD
Terazosin—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.000857	0.0322	CcSEcCtD
Terazosin—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.000835	0.0314	CcSEcCtD
Terazosin—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.000753	0.0283	CcSEcCtD
Terazosin—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.00068	0.0256	CcSEcCtD
Terazosin—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00061	0.0229	CcSEcCtD
Terazosin—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.000585	0.022	CcSEcCtD
Terazosin—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.000582	0.0219	CcSEcCtD
Terazosin—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00058	0.0218	CcSEcCtD
Terazosin—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.000566	0.0213	CcSEcCtD
Terazosin—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.000561	0.0211	CcSEcCtD
Terazosin—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.000557	0.0209	CcSEcCtD
Terazosin—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.000501	0.0188	CcSEcCtD
Terazosin—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00047	0.0177	CcSEcCtD
Terazosin—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.000457	0.0172	CcSEcCtD
Terazosin—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.000452	0.017	CcSEcCtD
Terazosin—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.000445	0.0167	CcSEcCtD
Terazosin—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.000435	0.0163	CcSEcCtD
Terazosin—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.000425	0.016	CcSEcCtD
Terazosin—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000424	0.0159	CcSEcCtD
Terazosin—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000424	0.0159	CcSEcCtD
Terazosin—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.000411	0.0155	CcSEcCtD
Terazosin—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.000409	0.0154	CcSEcCtD
Terazosin—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.000392	0.0148	CcSEcCtD
Terazosin—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000388	0.0146	CcSEcCtD
Terazosin—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000377	0.0142	CcSEcCtD
Terazosin—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.000365	0.0137	CcSEcCtD
Terazosin—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00035	0.0131	CcSEcCtD
Terazosin—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000341	0.0128	CcSEcCtD
Terazosin—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000336	0.0126	CcSEcCtD
Terazosin—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.000334	0.0126	CcSEcCtD
Terazosin—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000334	0.0125	CcSEcCtD
Terazosin—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.000331	0.0124	CcSEcCtD
Terazosin—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000321	0.0121	CcSEcCtD
Terazosin—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000319	0.012	CcSEcCtD
Terazosin—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000316	0.0119	CcSEcCtD
Terazosin—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000311	0.0117	CcSEcCtD
Terazosin—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000307	0.0115	CcSEcCtD
Terazosin—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000306	0.0115	CcSEcCtD
Terazosin—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000297	0.0112	CcSEcCtD
Terazosin—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000295	0.0111	CcSEcCtD
Terazosin—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00029	0.0109	CcSEcCtD
Terazosin—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00029	0.0109	CcSEcCtD
Terazosin—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00029	0.0109	CcSEcCtD
Terazosin—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000289	0.0109	CcSEcCtD
Terazosin—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000287	0.0108	CcSEcCtD
Terazosin—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000284	0.0107	CcSEcCtD
Terazosin—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00028	0.0105	CcSEcCtD
Terazosin—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000278	0.0105	CcSEcCtD
Terazosin—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000278	0.0105	CcSEcCtD
Terazosin—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000272	0.0102	CcSEcCtD
Terazosin—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000269	0.0101	CcSEcCtD
Terazosin—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000265	0.00996	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000253	0.00952	CcSEcCtD
Terazosin—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000252	0.00945	CcSEcCtD
Terazosin—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00025	0.00939	CcSEcCtD
Terazosin—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000248	0.00932	CcSEcCtD
Terazosin—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000247	0.00929	CcSEcCtD
Terazosin—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000245	0.0092	CcSEcCtD
Terazosin—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000242	0.00909	CcSEcCtD
Terazosin—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00024	0.00901	CcSEcCtD
Terazosin—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000238	0.00894	CcSEcCtD
Terazosin—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000238	0.00894	CcSEcCtD
Terazosin—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000229	0.00861	CcSEcCtD
Terazosin—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000227	0.00855	CcSEcCtD
Terazosin—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00022	0.00826	CcSEcCtD
Terazosin—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00022	0.00826	CcSEcCtD
Terazosin—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000205	0.0077	CcSEcCtD
Terazosin—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.0002	0.0075	CcSEcCtD
Terazosin—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000197	0.0074	CcSEcCtD
Terazosin—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00019	0.00715	CcSEcCtD
Terazosin—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000184	0.00691	CcSEcCtD
Terazosin—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000177	0.00665	CcSEcCtD
Terazosin—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000175	0.00659	CcSEcCtD
Terazosin—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000175	0.00658	CcSEcCtD
Terazosin—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000174	0.00655	CcSEcCtD
Terazosin—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000165	0.00621	CcSEcCtD
